Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immune response and safety of a combined diphtheria-tetanus-acellular pertussis vaccine (dTpa) in healthy Japanese adolescents aged 11 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• diphtheria-tetanus-acellular pertussis vaccine (dTpa) (diphtheria-tetanus-acellular pertussis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Status: ACTIVE_NOT_RECRUITING